Literature DB >> 28796005

Clinical spectrum of anti-Jo-1-associated disease.

Sara Monti1, Carlomaurizio Montecucco, Lorenzo Cavagna.   

Abstract

PURPOSE OF REVIEW: To provide the most recent evidence on anti-Jo-1 syndrome. RECENT
FINDINGS: Several new evidences on anti-Jo-1 syndrome have recently emerged. It has been clearly established that, at disease onset, the classic clinical triad (arthritis, myositis and interstitial lung disease - ILD) is only rarely observed. Indeed, disease onset with an isolated arthritis is common. Patients presenting with an isolated manifestation are at high risk for the subsequent occurrence of initially lacking triad findings. Moreover, the ex-novo occurrence of accompanying features such as Raynaud's phenomenon, mechanic's hands and fever during follow-up is a strong risk factor for the occurrence of overt antisynthetase syndrome (ASSD) with further triad manifestations. Several contributions on ILD involvement and prognosis have been published, as well as the distinctive muscle MRI characteristics compared with healthy controls, and a novel definition of a rare skin manifestation (hiker's feet).
SUMMARY: Recent evidence has shed a light on the need for a better understanding of the clinical course, imaging modalities and prognosis of anti-Jo-1 syndrome, providing some relevant elements to allow early diagnosis of this often unrecognized disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28796005     DOI: 10.1097/BOR.0000000000000434

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  Antisynthetase syndrome and interstitial lung disease: A case report.

Authors:  Krishna Dahal; Anand Chaudhary; Laba Rawal; Umesh Ray; Sandip Paudel; Pitambar Khanal; Pawan Gyawali; Sanjit Kumar Sah; Kishan Kumar Shrestha; Shailendra Pandey
Journal:  Ann Med Surg (Lond)       Date:  2022-09-08

Review 2.  Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Authors:  Alain Meyer; Carlo Alberto Scirè; Rosaria Talarico; Tobias Alexander; Zahir Amoura; Tadej Avcin; Simone Barsotti; Lorenzo Beretta; Jelena Blagojevic; Gerd Burmester; Ilaria Cavazzana; Patrick Cherrin; Laura Damian; Andrea Doria; João Eurico Fonseca; Federica Furini; Ilaria Galetti; Frederic Houssiau; Thomas Krieg; Larosa Maddalena; David Launay; Raquel Campanilho-Marques; Thierry Martin; Marco Matucci-Cerinic; Pia Moinzadeh; Carlomaurizio Montecucco; Maria Francisca Moraes-Fontes; Luc Mouthon; Rossella Neri; Sabrina Paolino; Yves Piette; Simona Rednic; Farah Tamirou; Angela Tincani; Natasa Toplak; Stefano Bombardieri; Eric Hachulla; Ulf Mueller-Ladner; Matthias Schneider; Vanessa Smith; Ana Vieira; Maurizio Cutolo; Marta Mosca; Lorenzo Cavagna
Journal:  RMD Open       Date:  2019-02-26

Review 3.  Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases.

Authors:  Valeria Nucera; Elisabetta Gerratana; Manuela Giallanza; Laura La Corte; Donatella Sangari; Fabiola Atzeni
Journal:  Drugs Context       Date:  2021-01-15

4.  Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.

Authors:  Xi Zhan; Wei Yan; Ying Wang; Qing Li; Xuhua Shi; Yanli Gao; Qiao Ye
Journal:  BMC Pulm Med       Date:  2021-02-12       Impact factor: 3.317

5.  Anti-synthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities-a case report with literature review.

Authors:  Nasam Alfraji; Usman Mazahir; Moiuz Chaudhri; Jeffrey Miskoff
Journal:  BMC Pulm Med       Date:  2021-01-06       Impact factor: 3.317

6.  Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study.

Authors:  Shuhui Sun; Zhiwei Chen; Danting Zhang; Wenwen Xu; Wanlong Wu; Fangfang Sun; Liyang Gu; Jie Chen; Jiajie Li; Ting Li; Xiaodong Wang; Shuang Ye
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 7.  Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome.

Authors:  Yongpeng Ge; Sizhao Li; Shanshan Li; Linrong He; Xin Lu; Guochun Wang
Journal:  Ther Adv Chronic Dis       Date:  2020-10-29       Impact factor: 5.091

8.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).

Authors:  Conor N Gruber; Roosheel S Patel; Rebecca Trachtman; Lauren Lepow; Fatima Amanat; Florian Krammer; Karen M Wilson; Kenan Onel; Daniel Geanon; Kevin Tuballes; Manishkumar Patel; Konstantinos Mouskas; Timothy O'Donnell; Elliot Merritt; Nicole W Simons; Vanessa Barcessat; Diane M Del Valle; Samantha Udondem; Gurpawan Kang; Sandeep Gangadharan; George Ofori-Amanfo; Uri Laserson; Adeeb Rahman; Seunghee Kim-Schulze; Alexander W Charney; Sacha Gnjatic; Bruce D Gelb; Miriam Merad; Dusan Bogunovic
Journal:  Cell       Date:  2020-09-14       Impact factor: 41.582

9.  The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients.

Authors:  Natasha Vijay Negalur; Gayatri G Ekbote; Dhiren N Raval; Dhaval V Tanna; Wasim S Kazi; Muzaffar A Bindroo; Durgarao J Yadavalli; Rajiva Gupta
Journal:  Ann Indian Acad Neurol       Date:  2021-05-21       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.